GPT Mouse

Glutamic-Pyruvate Transaminase Mouse Recombinant
Shipped with Ice Packs
In Stock

Description

gpt Delta Transgenic Mouse Model

The gpt delta mouse is a genetically engineered rodent designed to detect in vivo mutations through two parallel selection systems:

  • gpt selection: Identifies point mutations via bacterial guanine phosphoribosyltransferase (GPT) gene mutations

  • Spi− selection: Detects large deletions (>1 kb) through lambda phage recombination defects

Key Genetic Features

ComponentDescription
Reporter geneE. coli gpt (456 bp) integrated into lambda EG10 vector
Selection mechanism6-thioguanine resistance (gpt) and P2 lysogen bypass (Spi−)
Host strainC57BL/6J mice with 5-10 transgene copies
Mutation frequencyBaseline: 5×10⁻⁵ (gpt), 5×10⁻⁷ (Spi−) in untreated mice

Recombinant Mouse GPT Enzyme

The glutamic-pyruvic transaminase (GPT) protein is a clinical biomarker for hepatic function, commercially produced as:

Applications in Genotoxicity Research

The gpt delta model has been used to evaluate 20+ carcinogens, demonstrating unique advantages:

Comparative Mutagenicity Data

ChemicalTarget Organgpt MF (×10⁻⁵)Spi− MF (×10⁻⁶)Key Finding
Benzo[a]pyreneLiver12.8 ± 1.93.2 ± 0.8Dose-dependent mutagenicity
PhenacetinKidney6.4 ± 0.71.1 ± 0.3Higher liver vs. kidney mutation frequency
2,4-DiaminotolueneLiver9.1 ± 1.22.8 ± 0.5Carcinogen-specific mutagenesis

Notable findings:

  • Gender-specific mutagenicity observed for dicyclanil (hepatocarcinogen) with 3.5× higher G:C→T:A mutations in female mice

  • 78-week phenacetin exposure showed cumulative mutation frequencies exceeding short-term studies by 2.8×

Technical Advancements

Recent developments include:

  • F344 gpt delta rats: Backcrossed for 15 generations to match standard toxicology models

  • Combined assays: Simultaneous tumorigenicity and mutagenicity evaluation in same animals

  • Oxidative damage linkage: 8-oxo-dG levels correlate with gpt mutation spectra (R²=0.87)

Limitations and Considerations

  • Plasmid rescue efficiency: Requires optimized cre-lox recombination in YG6020 E. coli

  • Homozygous lethality: gpt delta rats show developmental defects in tooth formation

  • Clinical correlation: Hepatic GPT enzyme levels do not predict transgenic mutation frequencies (r=0.12)

Product Specs

Introduction
GPT (Glutamate Pyruvate Transaminase) is an enzyme that facilitates the reversible transfer of an amino group between alanine and 2-oxoglutarate, resulting in the formation of pyruvate and glutamate. This enzyme plays a vital role in the metabolism of glucose and amino acids. GPT levels are frequently measured in clinical settings as an indicator of liver health and to detect potential liver damage.
Description
Recombinant GPT Mouse protein, expressed in E.Coli, is a single polypeptide chain lacking glycosylation. It consists of 519 amino acids, with amino acids 1-496 representing the main protein sequence, and has a molecular weight of 57.5kDa. The protein includes a 23 amino acid His-tag attached to the N-terminus and is purified using proprietary chromatographic methods.
Physical Appearance
Sterile filtered solution, colorless in appearance.
Formulation
The GPT protein solution is provided at a concentration of 0.5mg/ml and contains the following components: Phosphate Buffered Saline at pH 7.4, 1mM DTT (dithiothreitol), and 10% glycerol.
Stability
For short-term storage (up to 2-4 weeks), the product should be kept refrigerated at 4°C. For extended storage, it is recommended to freeze the product at -20°C. Adding a carrier protein such as HSA or BSA at a concentration of 0.1% is advised for long-term storage to maintain protein stability. Avoid repeated freeze-thaw cycles.
Purity
The purity of the GPT protein is greater than 90% as assessed by SDS-PAGE analysis.
Biological Activity
The specific activity of the enzyme is determined to be greater than 40 units per milligram of protein. This value represents the enzyme's ability to convert 1 micromole of L-Alanine to L-Glutamate per minute at a pH of 7.5 and a temperature of 37°C.
Synonyms

Alanine aminotransferase 1, ALT1, Glutamate pyruvate transaminase 1, GPT 1, Glutamic--alanine transaminase 1, Glutamic--pyruvic transaminase 1.

Source
Escherichia Coli.
Amino Acid Sequence

MGSSHHHHHH SSGLVPRGSH MGSMASQRND RIQASRNGLK GKVLTLDTMN PCVRRVEYAV RGPIVQRALE LEQELRQGVK KPFTEVIRAN IGDAQAMGQR PITFFRQVLA LCVYPNLLSS PDFPEDAKRR AERILQACGG HSLGAYSISS GIQPIREDVA QYIERRDGGI PADPNNIFLS TGASDAIVTM LKLLVAGEGR ARTGVLIPIP QYPLYSAALA ELDAVQVDYY LDEERAWALD IAELRRALCQ ARDRCCPRVL CVINPGNPTG QVQTRECIEA VIRFAFEEGL FLMADEVYQD NVYAEGSQFH SFKKVLTEMG PPYATQQELA SFHSVSKGYM GECGFRGGYV EVVNMDAEVQ KQMAKLMSVR LCPPVPGQAL MGMVVSPPTP SEPSFKQFQA ERQEVLAELA AKAKLTEQVF NEAPGIRCNP VQGAMYSFPQ IQLPLKAVQR AQDLGLAPDM FFCLCLLEET GICVVPGSGF GQQEGTYHFR MTILPPMEKL RVLLEKLRHF HAKFTHEYS.

Q&A

What is a GPT Mouse?

GPT Mouse, more precisely known as gpt delta mouse, is a transgenic rodent model carrying the bacterial gpt (guanine phosphoribosyltransferase) gene as a reporter for mutation detection. This model was established by microinjection of lambda EG10 DNA into fertilized eggs of BDF1 or C57BL/6J mice. The most commonly used line (#30) originated from C57BL/6J mice and was selected for its high rescue efficiency and low spontaneous mutation frequencies . The gpt delta mouse serves as a valuable tool for in vivo mutation assays, allowing researchers to detect both point mutations and deletions in various tissues.

How does the gpt delta transgenic mouse system work?

The gpt delta system utilizes two distinct selection methods to detect different types of mutations:

  • gpt selection: For point mutations, the system employs positive selection with 6-thioguanine (6-TG). When genomic DNA from the mouse is extracted, the lambda phage vectors containing the gpt gene are rescued by in vitro packaging. These phages are then used to infect E. coli, and the colonies harboring plasmids with mutated gpt genes are selected on plates containing 6-TG and chloramphenicol .

  • Spi− selection: This method detects deletions. The selection identifies phages that can grow on E. coli strains missing recombination and repair functions, allowing for the detection of deletion mutations that might be overlooked by other systems due to high background levels of spontaneous base substitutions .

This dual-selection approach provides a comprehensive view of genetic alterations, making the system particularly valuable for genotoxicity studies.

What are the main applications of GPT Mouse models in research?

GPT Mouse models have been primarily utilized in two major research areas:

  • Radiation Biology: GPT delta mice are used to study the mutagenic effects of radiation exposure. After irradiation, mutations in various organs are analyzed to understand radiation-induced genetic damage .

  • Chemical Safety Evaluation: These models are extensively employed to assess the genotoxic potential of various chemicals, particularly in the context of food safety and pharmaceutical development .

Research AreaApplication ExamplesKey Advantages
Radiation BiologyMutation analysis after radiation exposureDetection of both point mutations and deletions
Chemical SafetyGenotoxicity assessment of food compounds, pharmaceuticalsAny organ can be analyzed, including germ cells
Food Safety ResearchExamination of mycotoxins, food additives, heterocyclic aminesExperimental conditions can mimic longer-term cancer bioassays
Carcinogenesis StudiesCorrelation between mutagenicity and carcinogenicityAnalysis of target and non-target organs of carcinogenesis

The gpt delta system has been particularly valuable in food safety research, with approximately 20 chemicals, including mycotoxins, food additives, and heterocyclic amines, examined using these models .

What are the comparative advantages of GPT Mouse versus GPT Rat models?

Both gpt delta mice and rats offer valuable but distinct advantages for mutation research:

CharacteristicGPT MouseGPT Rat
Primary UseGeneral genotoxicity studiesToxicology studies, 2-year cancer bioassays
Genetic BackgroundAvailable in C57BL/6J and B6C3F1 backgroundsAvailable in Sprague Dawley (SD) and Fischer 344 (F344) strains
Experimental ScaleSmaller animal size, lower compound requirementsBetter suited for long-term studies with larger tissue samples
Species-Specific ResponsesMay be resistant to certain carcinogens (e.g., aflatoxin B1)Better model for certain human-relevant carcinogens
Homozygous ViabilityHomozygous mice are viableHomozygous rats showed developmental issues (retarded teeth development)

The choice between mouse and rat models should be guided by the specific research questions. Rats are particularly valuable when examining species-specific carcinogens, as demonstrated with aflatoxin B1, which is carcinogenic in humans and rats but not in mice .

How has the GPT Mouse model contributed to understanding the relationship between mutagenicity and carcinogenicity?

The gpt delta system has provided crucial insights into the complex relationship between mutagenicity and carcinogenicity through several key observations:

  • Organ-Specific Responses: Studies with phenacetin in gpt delta rats revealed that mutation frequencies were higher in the liver (non-target organ for carcinogenesis) than in the kidney (target organ), suggesting that the intensity of genotoxicity does not always correlate with tumor formation .

  • Isomer Comparison Studies: Research comparing 2,4-diaminotoluene (a liver carcinogen) and its non-carcinogenic structural isomer 2,6-diaminotoluene demonstrated that only the carcinogenic isomer induced mutations in the liver of F344 gpt delta rats .

  • Long-Term Studies: Extended administration periods (8 weeks, 13 weeks, and in one case 78 weeks) designed to mimic cancer bioassays have shown how mutation accumulation relates to carcinogenic outcomes .

These findings highlight that while genotoxicity is often involved in carcinogenesis, the relationship is not always straightforward, and tissue-specific factors play critical roles in determining carcinogenic outcomes.

What methodological considerations are important when designing experiments with GPT Mouse models?

Researchers should consider several key methodological aspects when designing experiments with gpt delta mice:

  • Administration Period: While the standard administration period is 4 weeks, longer periods (8-13 weeks) may be more appropriate when mimicking cancer bioassays or examining cumulative genetic damage .

  • Genetic Background: Consider using B6C3F1 gpt delta mice (created by crossing C57BL/6J gpt delta mice with C3H/He mice) when comparative data with standard two-year cancer bioassays is needed .

  • Target Tissue Selection: Multiple tissues should be examined, including both expected target organs for toxicity and non-target tissues for comprehensive assessment.

  • Control Selection: Appropriate positive and negative controls are essential, particularly when assessing weak mutagens or when results are ambiguous.

  • Sequencing Analysis: Molecular characterization of mutations provides valuable mechanistic insights beyond simple mutant frequency calculations.

These considerations ensure that experimental designs maximize the informative value of the gpt delta system while minimizing potential confounding factors.

How can CRISPR technologies complement GPT Mouse research?

The emerging CRISPR-GPT systems offer powerful complementary approaches to traditional gpt delta mouse research:

  • Experimental Design Automation: CRISPR-GPT, an LLM agent enhanced with domain knowledge and external tools, can automate and enhance the design process of CRISPR-based gene-editing experiments, potentially including modifications to gpt delta systems .

  • Guide RNA Design: CRISPR-GPT can assist in designing guide RNAs, recommending cellular delivery methods, drafting protocols, and designing validation experiments to confirm editing outcomes .

  • Task Execution: The CRISPR-GPT system implements 22 tasks in the form of state machines, providing robust subgoal decomposition and progress control for gene-editing experimental design .

  • Human-Agent Collaboration: Biological experiments through human-agent collaboration using CRISPR-GPT have been validated in wet-lab settings, demonstrating the potential for enhancing gene-editing experiments in various research contexts .

The integration of CRISPR technologies with gpt delta mouse research could potentially enhance the precision of genetic modifications and expand the applications of these models in studying mutation and repair processes.

What are the potential pitfalls in GPT Mouse data analysis and how can they be avoided?

Researchers working with gpt delta mouse data should be aware of several common analytical challenges:

  • Background Mutation Rates: Spontaneous mutations, particularly C to T transitions at CpG sites due to the high methylation of bacterial transgenes in mammalian cells, can create background noise . Proper control groups and statistical analysis are essential for distinguishing treatment-induced mutations from background.

  • Data Analysis Tool Limitations: Researchers should be cautious about using AI tools like ChatGPT for data analysis, as these systems may produce plausible-looking but incorrect results. A study showed that ChatGPT hallucinates in 46% of answers for complex, relational datasets . For critical mutation data analysis, specialized bioinformatics tools and manual verification are recommended.

  • Mutation Spectrum Analysis: Simply reporting mutant frequencies without analyzing the types and positions of mutations can lead to incomplete interpretations. Full sequencing and spectrum analysis provide deeper mechanistic insights.

  • Inter-Laboratory Variability: Standardization of protocols across laboratories is essential for comparing results, as variations in lambda phage recovery efficiency and selection conditions can affect outcomes.

To mitigate these challenges, researchers should employ rigorous statistical methods, use appropriate positive and negative controls, perform comprehensive molecular characterization of mutations, and validate findings using complementary approaches.

Product Science Overview

Structure and Function

GPT belongs to the class-I pyridoxal-phosphate-dependent aminotransferase family and has two distinct molecular and genetic forms: one cytoplasmic (soluble) known as GPT1 and one mitochondrial known as GPT2 . The enzyme is a single, non-glycosylated polypeptide chain containing 519 amino acids and has a molecular mass of approximately 57.5 kDa .

Biological Importance

GPT is widely used as an indicator of liver health or hepatocellular damage in clinical tests . Its activity is measured to assess liver function, as elevated levels of GPT in the blood can indicate liver damage or disease. The enzyme’s role in converting alanine and alpha-ketoglutarate to glutamate and pyruvate is essential for the metabolism of amino acids and glucose .

Recombinant Production

The recombinant form of GPT from mice is produced in Escherichia coli (E. coli). This recombinant protein is often used in research and clinical applications due to its high purity and specific activity . The production process involves the expression of the GPT gene in E. coli, followed by purification using proprietary chromatographic techniques .

Applications

Recombinant GPT is used in various research applications, including studies on liver function, metabolism, and enzyme kinetics. It is also employed in the development of diagnostic assays for liver diseases .

Storage and Stability

The recombinant GPT protein is typically stored at 4°C for short-term use and at -20°C for long-term storage. It is recommended to avoid multiple freeze-thaw cycles to maintain the protein’s stability and activity .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.